n 0437, (-)-isomer has been researched along with Erythema in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Alba-Alcántara, L; Bermejo, PE; Ruiz-Huete, C; Zea, MA | 1 |
LeWitt, PA; Lyons, KE; Pahwa, R | 1 |
1 trial(s) available for n 0437, (-)-isomer and Erythema
Article | Year |
---|---|
Advanced Parkinson disease treated with rotigotine transdermal system: PREFER Study.
Topics: Administration, Cutaneous; Aged; Dopamine Agonists; Double-Blind Method; Drug Administration Routes; Drug Administration Schedule; Dyskinesia, Drug-Induced; Erythema; Female; Humans; Male; Middle Aged; Parkinson Disease; Placebos; Pruritus; Tetrahydronaphthalenes; Thiophenes; Time Factors; Treatment Outcome | 2007 |
1 other study(ies) available for n 0437, (-)-isomer and Erythema
Article | Year |
---|---|
[Local effects of transdermal treatment with rotigotine].
Topics: Aged; Antiparkinson Agents; Dopamine Agonists; Drug Evaluation; Drug Therapy, Combination; Equipment Failure; Erythema; Female; Humans; Male; Middle Aged; Pain; Patient Acceptance of Health Care; Retrospective Studies; Tetrahydronaphthalenes; Thiophenes; Transdermal Patch | 2013 |